Of the molecular subtypes of breast cancer, the triple-negative subtype (triple-negative breast cancers [TNBCs]), in which hormone receptors (HRs: estrogen receptor [ER] and progesterone receptor [PR]) and HER2 are not expressed, is reported to be the most diverse group [2, 3]. Here, ERBB2 is linked to breast carcinoma.